Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
383.00    2.00 (0.52%)
Bid:
378.00
Ask:
384.50
Spread: 6.50 (1.72%)
Market Cap: £1.96b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Directorate Change

29 Jul 2025 16:32

RNS Number : 0414T
Caledonia Investments PLC
29 July 2025
 

 

Caledonia Investments plc

 

Directorate change

 

Caledonia Investments plc ("Caledonia" or the "Company") announces that Lynn Fordham, who has served as a non-executive director of the Company since 1 January 2022, has given notice of her resignation with effect from 31 August 2025.

 

Farah Buckley, who has served on the Board since March 2023, has been appointed as an additional member of the Company's Audit and Risk Committee from 1 August 2025 and will succeed Lynn as its chair on 1 September 2025. The Board will now begin the search for an additional non-executive director.

 

David Stewart, Caledonia's Chair, commented:

 

"On behalf of the Board, I would like to thank Lynn for the considerable contribution that she has made to Caledonia and wish her well for the future.

 

"I am delighted that Farah will join the Audit and Risk Committee and will succeed Lynn as its chair."

 

Enquiries

 

Company contacts

Caledonia Investments plc

+44 20 7802 8080

investorrelations@caledonia.com

 

David Stewart

Chairman

Media contacts

Teneo

+44 20 7353 4200

Tom Murray

Robert Yates

 

caledonia@teneo.com

29 July 2025

 

Notes:

 

In accordance with section 430 (2B) of the Companies Act 2006, Caledonia confirms that, other than fees payable to Lynn Fordham as a non-executive director up to the effective date of her resignation, no remuneration or payment has been or will be made in connection with her cessation as a director of the Company.

 

Caledonia Investments plc

 

Caledonia is a FTSE 250 self-managed investment trust company with a long track record of delivering consistent returns and progressive annual dividend payments to shareholders.

 

Our aim is to generate long-term compounding real returns that outperform inflation by 3%-6% over the medium to long term, and the FTSE All-Share index over 10 years.

 

We are a long-term investor and hold investments in both listed and private markets across three pools: Public Companies, Private Capital and Funds. Each has a strategic allocation of capital, investment strategy and target return. The result is a well-balanced diversified portfolio of investments with a global reach.

 

For additional information on Caledonia, please visit www.caledonia.com.

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPUUWMUPAGAB
Date   Source Headline
21st Jul 201612:59 pmRNSResult of AGM
12th Jul 20164:31 pmRNSDirector/PDMR Shareholding
12th Jul 20164:29 pmRNSDirector/PDMR Shareholding
12th Jul 201612:18 pmRNSForm 8.3 - Avanti Communications Group plc
11th Jul 20164:54 pmRNSDirector/PDMR Shareholding
6th Jul 201612:38 pmRNSInterim Management Statement
6th Jul 201610:43 amRNSAcquisition
6th Jul 20167:00 amRNSNet Asset Value(s)
1st Jul 20168:19 amRNSBlock listing Interim Review
14th Jun 20168:50 amRNSAnnual Financial Report
6th Jun 20163:44 pmRNSNet Asset Value(s)
2nd Jun 20164:07 pmRNSDirector/PDMR Shareholding
27th May 20163:34 pmRNSDirector/PDMR Shareholding
27th May 20163:26 pmRNSDirector/PDMR Shareholding
27th May 20162:00 pmRNSHolding(s) in Company
26th May 20165:44 pmRNSRelated party transaction
19th May 20167:00 amRNSFinal Results 31 March 2016
9th May 20169:12 amRNSNet Asset Value(s)
4th May 20169:47 amRNSHolding(s) in Company
3rd May 201610:53 amRNSDisposal
8th Apr 20162:02 pmRNSDirector/PDMR Shareholding
7th Apr 201612:10 pmRNSNet Asset Value(s)
5th Apr 201612:50 pmRNSHolding(s) in Company
30th Mar 20162:05 pmRNSTransaction in Own Shares
23rd Mar 201611:54 amRNSDirector/PDMR Shareholding
16th Mar 20164:42 pmRNSDirector/PDMR Shareholding
8th Mar 20163:58 pmRNSDirectorate Change
4th Mar 20169:20 amRNSNet Asset Value(s)
24th Feb 20167:00 amRNSDividend Declaration
22nd Feb 20169:45 amRNSHome Member State Disclosure
4th Feb 20169:41 amRNSNet Asset Value(s)
18th Jan 20162:07 pmRNSDirector/PDMR Shareholding
7th Jan 20162:34 pmRNSInterim Management Statement
7th Jan 20162:23 pmRNSNet Asset Value(s)
4th Jan 20169:49 amRNSBlocklisting Interim Review
21st Dec 20157:00 amRNSAcquisition
8th Dec 20158:14 amRNSHalf Yearly Report
7th Dec 20159:08 amRNSNet Asset Value(s)
19th Nov 20157:00 amRNSHalf Yearly Report
9th Nov 20159:28 amRNSNet Asset Value(s)
26th Oct 20157:00 amRNSAcquisition
7th Oct 20152:20 pmRNSNet Asset Value(s)
30th Sep 20155:26 pmRNSTransaction in Own Shares
29th Sep 20154:18 pmRNSDirector/PDMR Shareholding
28th Sep 20158:12 amRNSDisposal
7th Sep 20153:20 pmRNSNet Asset Value(s)
7th Sep 201512:40 pmRNSAcquisition
1st Sep 201512:45 pmRNSChange of Registered Office
7th Aug 20159:26 amRNSNet Asset Value(s)
29th Jul 201511:32 amRNSForm 8.3 - Quintain Estates & Development

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.